China · Delayed Price · Currency is CNY Huaren Pharmaceutical Statistics
Total Valuation
SHE:300110 has a market cap or net worth of CNY 3.38 billion. The enterprise value is 4.52 billion.
| Market Cap | 3.38B |
| Enterprise Value | 4.52B |
Important Dates
The last earnings date was Thursday, August 27, 2026.
| Earnings Date | Aug 27, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SHE:300110 has 1.18 billion shares outstanding. The number of shares has increased by 0.17% in one year.
| Current Share Class | 1.18B |
| Shares Outstanding | 1.18B |
| Shares Change (YoY) | +0.17% |
| Shares Change (QoQ) | +0.37% |
| Owned by Insiders (%) | 0.28% |
| Owned by Institutions (%) | 9.64% |
| Float | 885.28M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.60 |
| PB Ratio | 3.60 |
| P/TBV Ratio | 8.77 |
| P/FCF Ratio | 12.39 |
| P/OCF Ratio | 11.44 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.31, with an EV/FCF ratio of 16.57.
| EV / Earnings | n/a |
| EV / Sales | 3.47 |
| EV / EBITDA | 20.31 |
| EV / EBIT | 39.58 |
| EV / FCF | 16.57 |
Financial Position
The company has a current ratio of 0.80, with a Debt / Equity ratio of 1.36.
| Current Ratio | 0.80 |
| Quick Ratio | 0.58 |
| Debt / Equity | 1.36 |
| Debt / EBITDA | 5.75 |
| Debt / FCF | 4.69 |
| Interest Coverage | 2.72 |
Financial Efficiency
Return on equity (ROE) is -39.80% and return on invested capital (ROIC) is 6.26%.
| Return on Equity (ROE) | -39.80% |
| Return on Assets (ROA) | 2.31% |
| Return on Invested Capital (ROIC) | 6.26% |
| Return on Capital Employed (ROCE) | 8.23% |
| Weighted Average Cost of Capital (WACC) | 4.91% |
| Revenue Per Employee | 511,026 |
| Profits Per Employee | -185,049 |
| Employee Count | 2,549 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 3.40 |
Taxes
In the past 12 months, SHE:300110 has paid 5.30 million in taxes.
| Income Tax | 5.30M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.63% in the last 52 weeks. The beta is 0.28, so SHE:300110's price volatility has been lower than the market average.
| Beta (5Y) | 0.28 |
| 52-Week Price Change | -15.63% |
| 50-Day Moving Average | 2.78 |
| 200-Day Moving Average | 3.05 |
| Relative Strength Index (RSI) | 50.94 |
| Average Volume (20 Days) | 29,462,299 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHE:300110 had revenue of CNY 1.30 billion and -471.69 million in losses. Loss per share was -0.40.
| Revenue | 1.30B |
| Gross Profit | 419.03M |
| Operating Income | 114.25M |
| Pretax Income | -462.85M |
| Net Income | -471.69M |
| EBITDA | 221.01M |
| EBIT | 114.25M |
| Loss Per Share | -0.40 |
Balance Sheet
The company has 212.74 million in cash and 1.28 billion in debt, with a net cash position of -1.07 billion or -0.90 per share.
| Cash & Cash Equivalents | 212.74M |
| Total Debt | 1.28B |
| Net Cash | -1.07B |
| Net Cash Per Share | -0.90 |
| Equity (Book Value) | 939.47M |
| Book Value Per Share | 0.73 |
| Working Capital | -271.52M |
Cash Flow
In the last 12 months, operating cash flow was 295.47 million and capital expenditures -22.62 million, giving a free cash flow of 272.85 million.
| Operating Cash Flow | 295.47M |
| Capital Expenditures | -22.62M |
| Depreciation & Amortization | 106.75M |
| Net Borrowing | -237.04M |
| Free Cash Flow | 272.85M |
| FCF Per Share | 0.23 |
Margins
Gross margin is 32.17%, with operating and profit margins of 8.77% and -36.21%.
| Gross Margin | 32.17% |
| Operating Margin | 8.77% |
| Pretax Margin | -35.53% |
| Profit Margin | -36.21% |
| EBITDA Margin | 16.97% |
| EBIT Margin | 8.77% |
| FCF Margin | 20.95% |
Dividends & Yields
SHE:300110 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.17% |
| Shareholder Yield | -0.17% |
| Earnings Yield | -13.95% |
| FCF Yield | 8.07% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 31, 2017. It was a forward split with a ratio of 1.5.
| Last Split Date | May 31, 2017 |
| Split Type | Forward |
| Split Ratio | 1.5 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |